Reinforce your understanding of nursing pharmacology and patient-centered care for NGN success and medication safety! Corresponding to the chapters in McCuistion’s Pharmacology: A Patient-Centered Nursing Process Approach, Twelfth Edition, this practical study guide provides hundreds of exercises, questions, drug calculation problems, and case studies to help you review and apply pharmacology and drug calculation concepts and content. The new edition features Next-Generation NCLEX® Examination (NGN)–style case studies to prepare your for the latest NCLEX® Exam. With this practical study guide, you will apply your knowledge of pharmacology to clinical practice, enhance your decision-making abilities, and develop your clinical judgment skills for NGN success and safe medication practice.
1. UNIT I: Introduction To Pharmacology - p. v 2. Clinical Judgment Management Model and the Nursing Process - p. 1 3. Drug Development and Ethical Considerations - p. 5 4. Pharmacokinetics and Pharmacodynamics - p. 7 5. Pharmacogenetics - p. 11 6. Complementary and Alternative Therapies - p. 13 7. Pediatric Considerations - p. 15 8. Geriatric Considerations - p. 17 9. Drugs in Substance Use Disorder - p. 21 10. UNIT II: Pharmacotherapy And Drug Administration - p. 22 11. Safety and Quality - p. 23 12. Drug Administration - p. 27 13. Drug Labels and Dosage Calculations - p. 29 14. UNIT III: Maintenance Of Homeostasis - p. 68 15. Fluid Volume and Electrolytes - p. 69 16. Vitamin and Mineral Replacement - p. 73 17. Nutritional Support - p. 77 18. UNIT IV: Autonomic Nervous System Drugs - p. 80 19. Adrenergic Agonists and Antagonists - p. 81 20. Cholinergic Agonists and Antagonists - p. 87 21. UNIT V: Central And Peripheral Nervous System Drugs - p. 90 22. Stimulants - p. 91 23. Depressants - p. 93 24. Antiseizure Drugs - p. 97 25. Drugs for Parkinsonism and Alzheimer Disease - p. 103 26. Drugs for Neuromuscular Disorders and Muscle Spasms - p. 107 27. UNIT VI: Mental And Behavioral Health Drugs - p. 110 28. Antipsychotics and Anxiolytics - p. 111 29. Antidepressants and Mood Stabilizers - p. 115 30. UNIT VII: Pain And Inflammation Management Drugs - p. 118 31. Antiinflammatories - p. 119 32. Analgesics - p. 123 33. UNIT VIII: Antimicrobial Drugs - p. 126 34. Penicillins, Other Beta-lactams, and Cephalosporins - p. 127 35. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, and Lipopeptides - p. 129 36. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones - p. 131 37. Sulfonamides and Nitroimidazoles Antibiotics - p. 135 38. Antituberculars, Antifungals, and Antivirals - p. 137 39. Antimalarials, Anthelmintics, and Peptides - p. 141 40. UNIT IX: Immunologic Drugs - p. 142 41. HIV- and AIDS-Related Drugs - p. 143 42. Transplant Drugs - p. 147 43. Vaccines - p. 149 44. UNIT X: Antineoplastics And Biologic Response Modifiers - p. 152 45. Anticancer Drugs - p. 153 46. Targeted Therapies to Treat Cancer - p. 157 47. Biologic Response Modifiers - p. 159 48. UNIT XI: Respiratory Drugs - p. 160 49. Upper Respiratory Disorders - p. 161 50. Lower Respiratory Disorders - p. 163 51. UNIT XII: Cardiovascular Drugs - p. 166 52. Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 167 53. Diuretics - p. 171 54. Antihypertensives - p. 175 55. Anticoagulants, Antiplatelets, and Thrombolytics - p. 181 56. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 185 57. UNIT XIII: Gastrointestinal Drugs - p. 186 58. Gastrointestinal Tract Disorders - p. 187 59. Antiulcer Drugs - p. 191 60. UNIT XIV: Eye, Ear, And Skin Drugs - p. 192 61. Eye and Ear Disorders - p. 193 62. Dermatologic Disorders - p. 197 63. UNIT XV: Endocrine Drugs - p. 198 64. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 199 65. Antidiabetics - p. 203 66. UNIT XVI: Renal And Urologic Drugs - p. 206 67. Urinary Disorders - p. 207 68. UNIT XVII: Reproductive And Gender-related Drugs - p. 210 69. Pregnancy and Preterm Labor - p. 211 70. Labor, Delivery, and Postpartum - p. 215 71. Neonatal and Newborn - p. 219 72. Women’s Reproductive Health - p. 221 73. Men’s Reproductive Health - p. 223 74. Sexually Transmitted Infections - p. 225 75. UNIT XVIII: Emergency Drugs - p. 226 76. Adult and Pediatric Emergency Drugs - p. 227 77. Answer Key - p. 231 78. Chapter 1: Clinical Judgment Management Model and the Nursing Process - p. 231 79. Chapter 2: Drug Development and Ethical Considerations - p. 232 80. Chapter 3: Pharmacokinetics and Pharmacodynamics - p. 233 81. Chapter 4: Pharmacogenetics - p. 234 82. Chapter 5: Complementary and Alternative Therapies - p. 235 83. Chapter 6: Pediatric Considerations - p. 236 84. Chapter 7: Geriatric Considerations - p. 237 85. Chapter 8: Drugs in Substance Use Disorder - p. 238 86. CHAPTER 9: SAFETY AND QUALITY - p. 239 87. Chapter 10: Drug Administration - p. 240 88. Chapter 11: Drug Labels and Dosage Calculations - p. 241 89. Chapter 12: Fluid Volume and Electrolytes - p. 245 90. Chapter 13: Vitamin and Mineral Replacement - p. 247 91. Chapter 14: Nutritional Support - p. 248 92. Chapter 15: Adrenergic Agonists and Antagonists - p. 250 93. Chapter 16: Cholinergic Agonists and Antagonists - p. 253 94. Chapter 17: Stimulants - p. 255 95. Chapter 18: Depressants - p. 256 96. Chapter 19: Antiseizure Drugs - p. 257 97. Chapter 20: Drugs for Parkinsonism and Alzheimer Disease - p. 261 98. Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms - p. 263 99. Chapter 22: Antipsychotics and Anxiolytics - p. 265 100. Chapter 23: Antidepressants and Mood Stabilizers - p. 266 101. Chapter 24: Antiinflammatories - p. 267 102. Chapter 25: Analgesics - p. 268 103. Chapter 26: Penicillins, Other Beta-Lactams, and Cephalosporins - p. 270 104. CHAPTER 27: MACROLIDES, OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES, AND LIPOPEPTIDES - p. 271 105. CHAPTER 28: TETRACYCLINES, GLYCYLCYCLINES, AMINOGLYCOSIDES, AND FLUOROQUINOLONES - p. 272 106. CHAPTER 29: SULFONAMIDES AND NITROIMIDAZOLES Antibiotics - p. 273 107. Chapter 30: Antituberculars, Antifungals, and Antivirals - p. 274 108. Chapter 31: Antimalarials, Anthelmintics, and Peptides - p. 276 109. Chapter 32: HIV- and AIDS-Related Drugs - p. 277 110. Chapter 33: Transplant Drugs - p. 278 111. Chapter 34: Vaccines - p. 279 112. Chapter 35: Anticancer Drugs - p. 280 113. Chapter 36: Targeted Therapies to Treat Cancer - p. 282 114. Chapter 37: Biologic Response Modifiers - p. 283 115. Chapter 38: Upper Respiratory Disorders - p. 283 116. Chapter 39: Lower Respiratory Disorders - p. 284 117. Chapter 40: Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 285 118. Chapter 41: Diuretics - p. 287 119. Chapter 42: Antihypertensives - p. 288 120. Chapter 43: Anticoagulants, Antiplatelets, and Thrombolytics - p. 291 121. Chapter 44: Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 292 122. Chapter 45: Gastrointestinal Tract Disorders - p. 293 123. Chapter 46: Antiulcer Drugs - p. 294 124. Chapter 47: Eye and Ear Disorders - p. 295 125. Chapter 48: Dermatologic Disorders - p. 296 126. Chapter 49: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 297 127. Chapter 50: Antidiabetics - p. 298 128. Chapter 51: Urinary Disorders - p. 299 129. Chapter 52: Pregnancy and Preterm Labor - p. 300 130. Chapter 53: Labor, Delivery, and Postpartum - p. 302 131. Chapter 54: Neonatal and Newborn - p. 303 132. CHAPTER 55: WOMEN’S REPRODUCTIVE HEALTH - p. 304 133. CHAPTER 56: MEN’S REPRODUCTIVE HEALTH - p. 305 134. Chapter 57: Sexually Transmitted Infections - p. 305 135. CHAPTER 58: ADULT AND PEDIATRIC EMERGENCY DRUGS - p. 306
Reinforce your understanding of nursing pharmacology and patient-centered care for NGN success and medication safety! Corresponding to the chapters in McCuistion’s Pharmacology: A Patient-Centered Nursing Process Approach, Twelfth Edition, this practical study guide provides hundreds of exercises, questions, drug calculation problems, and case studies to help you review and apply pharmacology and drug calculation concepts and content. The new edition features Next-Generation NCLEX® Examination (NGN)–style case studies to prepare your for the latest NCLEX® Exam. With this practical study guide, you will apply your knowledge of pharmacology to clinical practice, enhance your decision-making abilities, and develop your clinical judgment skills for NGN success and safe medication practice.
1. UNIT I: Introduction To Pharmacology - p. v 2. Clinical Judgment Management Model and the Nursing Process - p. 1 3. Drug Development and Ethical Considerations - p. 5 4. Pharmacokinetics and Pharmacodynamics - p. 7 5. Pharmacogenetics - p. 11 6. Complementary and Alternative Therapies - p. 13 7. Pediatric Considerations - p. 15 8. Geriatric Considerations - p. 17 9. Drugs in Substance Use Disorder - p. 21 10. UNIT II: Pharmacotherapy And Drug Administration - p. 22 11. Safety and Quality - p. 23 12. Drug Administration - p. 27 13. Drug Labels and Dosage Calculations - p. 29 14. UNIT III: Maintenance Of Homeostasis - p. 68 15. Fluid Volume and Electrolytes - p. 69 16. Vitamin and Mineral Replacement - p. 73 17. Nutritional Support - p. 77 18. UNIT IV: Autonomic Nervous System Drugs - p. 80 19. Adrenergic Agonists and Antagonists - p. 81 20. Cholinergic Agonists and Antagonists - p. 87 21. UNIT V: Central And Peripheral Nervous System Drugs - p. 90 22. Stimulants - p. 91 23. Depressants - p. 93 24. Antiseizure Drugs - p. 97 25. Drugs for Parkinsonism and Alzheimer Disease - p. 103 26. Drugs for Neuromuscular Disorders and Muscle Spasms - p. 107 27. UNIT VI: Mental And Behavioral Health Drugs - p. 110 28. Antipsychotics and Anxiolytics - p. 111 29. Antidepressants and Mood Stabilizers - p. 115 30. UNIT VII: Pain And Inflammation Management Drugs - p. 118 31. Antiinflammatories - p. 119 32. Analgesics - p. 123 33. UNIT VIII: Antimicrobial Drugs - p. 126 34. Penicillins, Other Beta-lactams, and Cephalosporins - p. 127 35. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, and Lipopeptides - p. 129 36. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones - p. 131 37. Sulfonamides and Nitroimidazoles Antibiotics - p. 135 38. Antituberculars, Antifungals, and Antivirals - p. 137 39. Antimalarials, Anthelmintics, and Peptides - p. 141 40. UNIT IX: Immunologic Drugs - p. 142 41. HIV- and AIDS-Related Drugs - p. 143 42. Transplant Drugs - p. 147 43. Vaccines - p. 149 44. UNIT X: Antineoplastics And Biologic Response Modifiers - p. 152 45. Anticancer Drugs - p. 153 46. Targeted Therapies to Treat Cancer - p. 157 47. Biologic Response Modifiers - p. 159 48. UNIT XI: Respiratory Drugs - p. 160 49. Upper Respiratory Disorders - p. 161 50. Lower Respiratory Disorders - p. 163 51. UNIT XII: Cardiovascular Drugs - p. 166 52. Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 167 53. Diuretics - p. 171 54. Antihypertensives - p. 175 55. Anticoagulants, Antiplatelets, and Thrombolytics - p. 181 56. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 185 57. UNIT XIII: Gastrointestinal Drugs - p. 186 58. Gastrointestinal Tract Disorders - p. 187 59. Antiulcer Drugs - p. 191 60. UNIT XIV: Eye, Ear, And Skin Drugs - p. 192 61. Eye and Ear Disorders - p. 193 62. Dermatologic Disorders - p. 197 63. UNIT XV: Endocrine Drugs - p. 198 64. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 199 65. Antidiabetics - p. 203 66. UNIT XVI: Renal And Urologic Drugs - p. 206 67. Urinary Disorders - p. 207 68. UNIT XVII: Reproductive And Gender-related Drugs - p. 210 69. Pregnancy and Preterm Labor - p. 211 70. Labor, Delivery, and Postpartum - p. 215 71. Neonatal and Newborn - p. 219 72. Women’s Reproductive Health - p. 221 73. Men’s Reproductive Health - p. 223 74. Sexually Transmitted Infections - p. 225 75. UNIT XVIII: Emergency Drugs - p. 226 76. Adult and Pediatric Emergency Drugs - p. 227 77. Answer Key - p. 231 78. Chapter 1: Clinical Judgment Management Model and the Nursing Process - p. 231 79. Chapter 2: Drug Development and Ethical Considerations - p. 232 80. Chapter 3: Pharmacokinetics and Pharmacodynamics - p. 233 81. Chapter 4: Pharmacogenetics - p. 234 82. Chapter 5: Complementary and Alternative Therapies - p. 235 83. Chapter 6: Pediatric Considerations - p. 236 84. Chapter 7: Geriatric Considerations - p. 237 85. Chapter 8: Drugs in Substance Use Disorder - p. 238 86. CHAPTER 9: SAFETY AND QUALITY - p. 239 87. Chapter 10: Drug Administration - p. 240 88. Chapter 11: Drug Labels and Dosage Calculations - p. 241 89. Chapter 12: Fluid Volume and Electrolytes - p. 245 90. Chapter 13: Vitamin and Mineral Replacement - p. 247 91. Chapter 14: Nutritional Support - p. 248 92. Chapter 15: Adrenergic Agonists and Antagonists - p. 250 93. Chapter 16: Cholinergic Agonists and Antagonists - p. 253 94. Chapter 17: Stimulants - p. 255 95. Chapter 18: Depressants - p. 256 96. Chapter 19: Antiseizure Drugs - p. 257 97. Chapter 20: Drugs for Parkinsonism and Alzheimer Disease - p. 261 98. Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms - p. 263 99. Chapter 22: Antipsychotics and Anxiolytics - p. 265 100. Chapter 23: Antidepressants and Mood Stabilizers - p. 266 101. Chapter 24: Antiinflammatories - p. 267 102. Chapter 25: Analgesics - p. 268 103. Chapter 26: Penicillins, Other Beta-Lactams, and Cephalosporins - p. 270 104. CHAPTER 27: MACROLIDES, OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES, AND LIPOPEPTIDES - p. 271 105. CHAPTER 28: TETRACYCLINES, GLYCYLCYCLINES, AMINOGLYCOSIDES, AND FLUOROQUINOLONES - p. 272 106. CHAPTER 29: SULFONAMIDES AND NITROIMIDAZOLES Antibiotics - p. 273 107. Chapter 30: Antituberculars, Antifungals, and Antivirals - p. 274 108. Chapter 31: Antimalarials, Anthelmintics, and Peptides - p. 276 109. Chapter 32: HIV- and AIDS-Related Drugs - p. 277 110. Chapter 33: Transplant Drugs - p. 278 111. Chapter 34: Vaccines - p. 279 112. Chapter 35: Anticancer Drugs - p. 280 113. Chapter 36: Targeted Therapies to Treat Cancer - p. 282 114. Chapter 37: Biologic Response Modifiers - p. 283 115. Chapter 38: Upper Respiratory Disorders - p. 283 116. Chapter 39: Lower Respiratory Disorders - p. 284 117. Chapter 40: Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 285 118. Chapter 41: Diuretics - p. 287 119. Chapter 42: Antihypertensives - p. 288 120. Chapter 43: Anticoagulants, Antiplatelets, and Thrombolytics - p. 291 121. Chapter 44: Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 292 122. Chapter 45: Gastrointestinal Tract Disorders - p. 293 123. Chapter 46: Antiulcer Drugs - p. 294 124. Chapter 47: Eye and Ear Disorders - p. 295 125. Chapter 48: Dermatologic Disorders - p. 296 126. Chapter 49: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 297 127. Chapter 50: Antidiabetics - p. 298 128. Chapter 51: Urinary Disorders - p. 299 129. Chapter 52: Pregnancy and Preterm Labor - p. 300 130. Chapter 53: Labor, Delivery, and Postpartum - p. 302 131. Chapter 54: Neonatal and Newborn - p. 303 132. CHAPTER 55: WOMEN’S REPRODUCTIVE HEALTH - p. 304 133. CHAPTER 56: MEN’S REPRODUCTIVE HEALTH - p. 305 134. Chapter 57: Sexually Transmitted Infections - p. 305 135. CHAPTER 58: ADULT AND PEDIATRIC EMERGENCY DRUGS - p. 306
